OVID Ovid Therapeutics Inc. Loading...

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
13:13
Jun 21
seedy19tron
Buy the "hot zone" biotech names (3–9 months post positive data) as the author's historical M&A.
Buy the "hot zone" biotech names (3–9 months post positive data) as the author's historical M&A timing framework shows this is the window where acquirers with pre-committed capital execute; sector M&A wave across radiopharmaceuticals, MASH, IBD, and obesity validates the pattern is active.
OVID Ovid Therapeutics Inc. Long 2ND — —
13:25
Mar 18
seedy19tron
The author expresses a positive outlook on OVID data and expects the stock price to exceed $3.
OVID Ovid Therapeutics Inc. Long — —
22:30
Feb 22
seedy19tron
Ovid position held unchanged
The author's Ovid Therapeutics position was unchanged this week, according to the weekly update. This is a bare holding disclosure with no reason given.
OVID Ovid Therapeutics Inc. Long Position: Holding —
Log in to see ideas

About OVID Investor Commentary

Across the available history and selected sources, Buzzberg tracks OVID (Ovid Therapeutics Inc.) across 2 sources: 5 bullish vs 0 bearish calls from 2 authors. Historical directional balance: 31% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 16 total trade ideas tracked. Latest voices: seedy19tron.